AUSTIN HARMON: Open Payments
NPI 1528758265 · DEWEY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,114 in 52 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $15 · 2025 $1,114
Food & beverage: $1,114
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $264 |
| Amgen Inc. | 13 | $184 |
| Exact Sciences Corporation | 5 | $115 |
| GlaxoSmithKline, LLC. | 5 | $101 |
| ABBVIE INC. | 4 | $93 |
| Lilly USA, LLC | 4 | $80 |
| Novo Nordisk Inc | 2 | $44 |
| PFIZER INC. | 2 | $38 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Aimmune Therapeutics, Inc. | 1 | $23 |
Products named: FARXIGA, TRELEGY ELLIPTA, The Cologuard Plus Collection Kit, AIRSUPRA, KRYSTEXXA, EVENITY, MOUNJARO, UBRELVY.
Industry payments across AZ — which companies pay providers there.
